allfeeds.ai

 

Rare Discussions  

Rare Discussions

Author: CheckRare Editors

Language: en

Genres: Health & Fitness, Medicine

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it


Get all podcast data

Listen Now...

Trutakna Meets All Prespecified Endpoints in Phase 3 ORIGIN 3 Trial in IgA Nephropathy
Tuesday, 17 November, 2026

Positive final efficacy results from the phase 3 ORIGIN 3 trial, evaluating Trutakna (atacicept) in adults with primary IgA nephropathy (IgAN) at risk of disease progression. Marshall Fordyce, MD, founder and CEO of Vera Therapeutics, discusses the findingsRare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.

 

We also recommend:


The COVID-19 LST Report
COVID19LST

Beckers Healthcare -- Ambulatory Surgery Centers Podcast
Becker's Healthcare

ROCKET SCIENCE | Gesundheit und Leistung mit Doc Golo

The Grand Round Up
The Grand Round Up

Sistema Sensorial
jliacherry

Be Perfectly Healthy
User 540661506


/

FISIO TE RESPONDE
Gabriel Boaventura

Uso de animais em experimentos
Yasmim Albuquerque

Dr. Bones
NPO Luister / HUMAN / VPRO

The DIGA Podcast
DIGA

BondAir
Bond Vet